Toggle light / dark theme

First CRISPR therapy administered in landmark human trial

The first confirmed CRISPR gene editing clinical trial to take place outside of China is officially underway, after pharmaceutical companies CRISPR Therapeutics and Vertex revealed a human patient has been administered the experimental treatment targeting a rare blood disease.